Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evolus Q3 EPS $(0.24) Beats $(0.26) Estimate, Sales $68.967M Beat $67.449M Estimate

Author: Benzinga Newsdesk | November 05, 2025 04:20pm
Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.26) by 8.75 percent. This is a 41.18 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $68.967 million which beat the analyst consensus estimate of $67.449 million by 2.25 percent. This is a 12.90 percent increase over sales of $61.085 million the same period last year.

Posted In: EOLS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist